Transplant Genomics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$71.5M
Transplant Genomics General Information
Description
Provider of molecular diagnostic tests intended for kidney and liver graft dysfunction. The company offers robust molecular signatures indicative of individual patient graft status, prognosis, or response to specific immunosuppressant regimens to complement histological analysis and resolve ambiguous or borderline results, thereby enabling doctors to improve organ transplant outcomes with noninvasive serial monitoring guided by genomics.
Contact Information
Website
www.transplantgenomics.com(Operating Subsidiary)
Corporate Office
- 18000 West 99th Street
- Lenexa, KS 66219
- United States
Corporate Office
- 18000 West 99th Street
- Lenexa, KS 66219
- United States
Transplant Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 25-Jun-2019 | $71.5M | Completed | Generating Revenue | ||
| 4. Later Stage VC (Series C) | 06-Sep-2018 | Completed | Generating Revenue | |||
| 3. Grant | Completed | Startup | ||||
| 2. Early Stage VC (Series B) | 03-Apr-2017 | $8.05M | $15.3M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 28-May-2015 | $7.29M | $7.29M | Completed | Startup |
Transplant Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A | 764,924 | $0.001000 | 8% | $9.9 | $9.9 | 1x | $9.9 | 14.99% |
Transplant Genomics Comparisons
Industry
Financing
Details
Transplant Genomics Competitors (3)
One of Transplant Genomics’s 3 competitors is Cleveland HeartLab, a Formerly VC-backed company based in Cleveland, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cleveland HeartLab | Formerly VC-backed | Cleveland, OH | ||||
| Clinical Reference Laboratory | Corporation | Lenexa, KS | ||||
| Boston Heart Diagnostics | Formerly VC-backed | Framingham, MA |
Transplant Genomics Patents
Transplant Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023343083-A1 | Methods, systems, and compositions for diagnosing pancreatic transplant rejection | Pending | 12-Sep-2022 | ||
| EP-4587593-A1 | Methods, systems, and compositions for diagnosing pancreatic transplant rejection | Pending | 12-Sep-2022 | ||
| US-20250327126-A1 | Methods, systems, and compositions for diagnosing pancreatic transplant rejection | Pending | 12-Sep-2022 | ||
| WO-2024059514-A1 | Methods, systems, and compositions for diagnosing pancreatic transplant rejection | Inactive | 12-Sep-2022 | ||
| CA-3228583-A1 | Methods of using donor-derived cell-free dna to distinguish acute rejection and other conditions in liver transplant recipients | Pending | 16-Sep-2021 | C12Q1/6883 |
Transplant Genomics Signals
Transplant Genomics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Founders Capital Partners | Angel Group | Minority | ||
| National Heart, Lung, and Blood Institute | Government | Minority | ||
| Rose Ventures | Venture Capital | Minority |
Transplant Genomics FAQs
-
When was Transplant Genomics founded?
Transplant Genomics was founded in 2013.
-
Where is Transplant Genomics headquartered?
Transplant Genomics is headquartered in Lenexa, KS.
-
What is the size of Transplant Genomics?
Transplant Genomics has 11 total employees.
-
What industry is Transplant Genomics in?
Transplant Genomics’s primary industry is Laboratory Services (Healthcare).
-
Is Transplant Genomics a private or public company?
Transplant Genomics is a Private company.
-
What is the current valuation of Transplant Genomics?
The current valuation of Transplant Genomics is .
-
What is Transplant Genomics’s current revenue?
The current revenue for Transplant Genomics is .
-
How much funding has Transplant Genomics raised over time?
Transplant Genomics has raised $23.3M.
-
Who are Transplant Genomics’s investors?
Founders Capital Partners, National Heart, Lung, and Blood Institute, and Rose Ventures have invested in Transplant Genomics.
-
Who are Transplant Genomics’s competitors?
Cleveland HeartLab, Clinical Reference Laboratory, and Boston Heart Diagnostics are competitors of Transplant Genomics.
-
When was Transplant Genomics acquired?
Transplant Genomics was acquired on 25-Jun-2019.
-
Who acquired Transplant Genomics?
Transplant Genomics was acquired by Eurofins Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process